pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
fda medwatch·Jul 9·2 min read
save

Early Alert: Convenience Kits Issue from Medline

Certain BD ChloraPrep Applicators in Convenience Kits manufactured by Medline may not be sterile.

Jul 9, 2026·read at fda medwatch ↗

CDRH is issuing this Early Alert to notify the public of a potentially high-risk device issue. The FDA will keep the public informed and update this web page as significant new information becomes available. Affected ProductThe FDA is aware that Medline has issued a letter to affected customers recommending certain convenience kits be removed from where they are used or sold.

Affected devices:Full list of Affected ProductsWhat to DoRemove affected BD ChloraPrep applicators. Apply over-labels to all affected kits on hand stating that the affected components must be removed and discarded prior to use.On June 12, Medline sent all affected customers a letter recommending the following actions:Immediately check your stock for any affected product and quarantine. Other components within the convenience kits may still be used.

Apply provided over-labels to any affected kits on hand stating that the affected component must be removed and discarded prior to use. If you are a distributor or have resold or transferred this product, notify them of this recall communication. Check this web page for updates.

The FDA is currently reviewing information about this potentially high-risk device issue and will keep the public informed as significant new information becomes available. Reason for AlertMedline stated that Becton, Dickinson and Company is conducting a Drug Recall of specific lots of the BD ChloraPrep™ Clear - 1 mL and FREPP™ Clear 1.5 mL Applicators due to a potential breach of sterility in the packaging, due to wrinkles in the paper lidding which may extend to the seal area. If the sterile barrier is compromised, patients and users may be exposed to microbial contamination.

Potential health consequences may include no injury, localized infection, or, less commonly, more serious infection requiring medical treatment, antimicrobial therapy, procedural intervention, or hospitalization. In rare cases, particularly in critically ill or immunocompromised patients, severe infection could become life-threatening. Patients who may have been exposed should be monitored according to clinical judgment for signs or symptoms of infection, and any suspected infection should be evaluated and treated promptly.

Patients who may have been exposed without complications do not require follow up.As of June 12, Medline has reported no serious injuries or no deaths associated with this issue.Device UseConvenience kits contain various surgical instruments, dressings and/or other materials, and pharmaceutical components that are intended to be used during various surgical procedures. Contact InformationCustomers in the U.S. with adverse reactions, quality problems, or questions about this issue should contact Medline at recalls@medline.com or 866-359-1704.Additional FDA Resources BD Issues Nationwide Recall for Specific Lots of ChloraPrep™ Clear Single Sterile 1 mL and FREPP™ Clear 1.5 mL Applicators Due to Microbial Contamination | FDA [06/08/2026] Unique Device Identifier (UDI)The unique device identifier (UDI) helps identify individual medical devices sold in the United States from distribution to use.

The UDI allows for more accurate reporting, reviewing, and analyzing of adverse event reports so that devices can be identified more quickly, and as a result, problems potentially resolved more quickly.How do I recognize a UDI on a label?AccessGUDID database - Identify Your Medical Device Benefits of a UDI SystemHow do I report a problem?Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program.

source

Reporting by fda medwatch.

read at fda medwatch ↗
541 words · retrieved 2h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 5d agoEarly Alert: Percutaneous Catheter Issue from Boston Scientificfda medwatch
  • Jul 20Early Alert: Intravascular Administration Set Issue from Baxterfda medwatch
  • Jul 17Catheter Introducer Kit Recall: Abiomed Removes 14Fr Low Profile Introducer Kitsfda medwatch
  • Jul 17Thoracic Stent Graft Recall: Bolton Medical Removes Relay Pro Systemfda medwatch
  • Jul 16Convenience Kit Recall: B. Braun Medical, Inc. Removes Spinal Anesthesia Kits Containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USPfda medwatch